Document Type
Article
Publication Date
10-6-2011
Abstract
The Greens/EFA Internet Core Group in the European Parliament, and a collection of its individual members, commissioned this analysis of potential impacts of the Anti-Counterfeiting Trade Agreement (ACTA) on access to medicines in developing countries.” On the whole, ACTA negotiators created an agreement that shifts international “hard law” rules and “soft law” encouragements toward making enforcement of intellectual property rights in courts, at borders, by the government and by private parties easier, less costly, and more “deterrent” in the level of penalties. In doing so, it increases the risks and consequences of wrongful searches, seizures, lawsuits and other enforcement actions for those relying on intellectual property limitations and exceptions to access markets, including the suppliers of legitimate generic medicines. This, in turn, is likely to make affordable medicines more scarce and dear in many countries.
Recommended Citation
Flynn, Sean and Madhani, Bijan, "ACTA and Access to Medicines" (2011). Joint PIJIP/TLS Research Paper Series. 22.
https://digitalcommons.wcl.american.edu/research/22
Comments
Prepared at the request of:
The Greens, European Free Alliance, 2011
American University, WCL Research Paper No. 2012-03